BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18490712)

  • 1. TLR Ligand-Induced Type I IFNs Affect Thymopoiesis.
    Baron ML; Gauchat D; La Motte-Mohs R; Kettaf N; Abdallah A; Michiels T; Zúñiga-Pflücker JC; Sékaly RP
    J Immunol; 2008 Jun; 180(11):7134-46. PubMed ID: 18490712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible blockade of thymic output: an inherent part of TLR ligand-mediated immune response.
    Démoulins T; Abdallah A; Kettaf N; Baron ML; Gerarduzzi C; Gauchat D; Gratton S; Sékaly RP
    J Immunol; 2008 Nov; 181(10):6757-69. PubMed ID: 18981093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of invariant NK T cells are modulated by TLR ligands and IFN-α.
    Villanueva AI; Haeryfar SM; Mallard BA; Kulkarni RR; Sharif S
    Innate Immun; 2015 Apr; 21(3):275-88. PubMed ID: 24934453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
    Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
    Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of γδ T cell responses by TLR ligands.
    Wesch D; Peters C; Oberg HH; Pietschmann K; Kabelitz D
    Cell Mol Life Sci; 2011 Jul; 68(14):2357-70. PubMed ID: 21560072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
    Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
    J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR activation pathways in HIV-1-exposed seronegative individuals.
    Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
    J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-stimulation with TLR3 and TLR21 ligands synergistically up-regulates Th1-cytokine IFN-γ and regulatory cytokine IL-10 expression in chicken monocytes.
    He H; Genovese KJ; Swaggerty CL; MacKinnon KM; Kogut MH
    Dev Comp Immunol; 2012 Apr; 36(4):756-60. PubMed ID: 22120532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Toll-like receptor that recognizes vesicular stomatitis virus.
    Shi Z; Cai Z; Sanchez A; Zhang T; Wen S; Wang J; Yang J; Fu S; Zhang D
    J Biol Chem; 2011 Feb; 286(6):4517-24. PubMed ID: 21131352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1.
    Zhan Z; Cao H; Xie X; Yang L; Zhang P; Chen Y; Fan H; Liu Z; Liu X
    J Immunol; 2015 Oct; 195(8):3849-57. PubMed ID: 26363053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
    Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
    J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
    Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
    Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens.
    Alkie TN; Taha-Abdelaziz K; Barjesteh N; Bavananthasivam J; Hodgins DC; Sharif S
    PLoS One; 2017; 12(1):e0169154. PubMed ID: 28045984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
    Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
    Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
    An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X
    Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.